After Hours Decliner
JAGX Jaguar Health5.32-0.70-11.6%
After Hours:5.22-0.10 (-1.9%)
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
ACCESS NewswireTue, 29-Sep 4:30 AM
Premarket Decliner
JAGX Jaguar Health5.84+0.08+1.4%
Premarket:5.33-0.51 (-8.7%)
Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
ACCESS NewswireWed, 21-May 8:01 AM
JAGX Jaguar Health0.400.00 (+0.3%)
JAGX Jaguar Health0.78+0.24 (+45.5%)
JAGX Jaguar Health1.65+0.50 (+43.5%)
JAGX Jaguar Health2.41+0.39 (+19.3%)
